Tag Archives: HMO

WACKER and BENEO Partner to Bring 2’-Fucosyllactose (2’-FL) to European Market for Infant Nutrition

(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release

Chr. Hansen’s MyOli™ 6’-SL HMO Receives EU Approval for Infant Formula and Follow-On Formula

(IN BRIEF) Chr. Hansen has received approval from the EU for their 6’-SL HMO, the final addition to their MyOli™ 5 HMO Mix. This authorization allows the highest use level of 6’-SL in infant formula and follow-on formula in the … Read the full press release

DSM adds Human Milk Oligosaccharides (HMO) to its portfolio with the acquisition of Glycom

(PRESS RELEASE) HEERLEN, the Netherlands, 21-Feb-2020 — /EuropaWire/ — Royal DSM has reached agreement to acquire Glycom A/S (“Glycom”), the world’s leading supplier of Human Milk Oligosaccharides (HMO). The transaction, worth €765 million, represents an EV/EBITDA multiple of 20.6x based … Read the full press release